Groupe Oncologie Radiotherapie Tete Et Cou
Clinical trials sponsored by Groupe Oncologie Radiotherapie Tete Et Cou, explained in plain language.
-
New Two-Pronged attack tested against tough head and neck cancers
Disease control Not yet recruitingThis study aims to see if using two newer drugs together before standard chemoradiation works better than using one of those drugs alone for people with advanced head and neck cancer. About 106 participants will be randomly assigned to receive either the single drug or the two-dr…
Phase: PHASE2 • Sponsor: Groupe Oncologie Radiotherapie Tete et Cou • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug duo challenges standard treatment in major head & neck cancer trial
Disease control Not yet recruitingThis study aims to see if new drug combinations can help people with advanced head and neck cancer live longer. It will compare two experimental treatments against the current standard therapy. About 780 patients whose cancer has returned or spread will participate. The main goal…
Phase: PHASE3 • Sponsor: Groupe Oncologie Radiotherapie Tete et Cou • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC